Venous congestion has emerged as an important cause of renal dysfunction in patients with
cardiorenal syndrome. However, only limited progress has been made in differentiating this …

Pulmonary arterial hypertension (PH) and chronic kidney disease (CKD) both profoundly
impact patient outcomes, whether as primary disease states or as co-morbid conditions. PH …

Results Age was 64.1±13.8 years old; 19% had diabetes, and 22% had CV disease. eGFR
was 39.9±20.2 ml/min per 1.73 m 2. LVH was detected in 249 patients (56.0%); of these, 125 …

Recent reports from worldwide pulmonary hypertension registries show a new demographic
picture for patients with idiopathic pulmonary arterial hypertension (IPAH), with an …

Pulmonary hypertension (PH) is associated with poor outcomes in the dialysis and general
populations, but its effect in CKD is unclear. We evaluated the prevalence and predictors of …

Rationale & Objective Pulmonary hypertension (PH) contributes to cardiovascular disease
and mortality in patients with chronic kidney disease (CKD), but the pathophysiology is …

Background We sought to study longer term survival in patients with aortic stenosis (AS) and
nondialysis chronic kidney disease (CKD). Methods and Results We studied 839 patients …

Background Pulmonary hypertension (PH) was recently recognized as a common
complication of end-stage renal disease (ESRD) that causes an increased risk of mortality …

Pulmonary hypertension (PH) is common in patients with chronic kidney disease (CKD) and
associated with increased mortality but the hemodynamic profiles, clinical risk factors, and …

Background Cystatin C is a novel biomarker to identify renal dysfunction and cardiovascular
risk. Objective The aim of this study was to investigate the role of cystatin C in non-invasive …